1. Home
  2. VYGR vs SBFG Comparison

VYGR vs SBFG Comparison

Compare VYGR & SBFG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Voyager Therapeutics Inc.

VYGR

Voyager Therapeutics Inc.

N/A

Current Price

$3.09

Market Cap

216.3M

Sector

Health Care

ML Signal

N/A

Logo SB Financial Group Inc.

SBFG

SB Financial Group Inc.

N/A

Current Price

$29.15

Market Cap

182.2M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
VYGR
SBFG
Founded
2013
1983
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
216.3M
182.2M
IPO Year
2015
2014

Fundamental Metrics

Financial Performance
Metric
VYGR
SBFG
Price
$3.09
$29.15
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$16.50
N/A
AVG Volume (30 Days)
404.5K
9.8K
Earning Date
05-08-2026
04-23-2026
Dividend Yield
N/A
2.98%
EPS Growth
N/A
27.33
EPS
N/A
1.41
Revenue
$10,135,000.00
N/A
Revenue This Year
$34.04
N/A
Revenue Next Year
$7.92
N/A
P/E Ratio
N/A
$20.67
Revenue Growth
N/A
N/A
52 Week Low
$2.94
$18.16
52 Week High
$5.55
$30.07

Technical Indicators

Market Signals
Indicator
VYGR
SBFG
Relative Strength Index (RSI) 42.00 58.23
Support Level $2.95 $20.94
Resistance Level $3.30 $30.07
Average True Range (ATR) 0.14 0.87
MACD -0.03 0.01
Stochastic Oscillator 13.19 64.61

Price Performance

Historical Comparison
VYGR
SBFG

About VYGR Voyager Therapeutics Inc.

Voyager Therapeutics Inc is a biotechnology company to leverage the power of human genetics to modify the course of and ultimately cure neurological diseases. Its pipeline includes programs for Alzheimer's disease, or AD; Friedreich's ataxia, or FA; Parkinson's disease, or PD; and multiple other diseases of the central nervous system, or CNS. Many of its programs are derived from its TRACER (Tropism Redirection of AAV by Cell-type-specific Expression of RNA) adeno-associated virus, or AAV, capsid discovery platform, which the company has used to generate novel capsids, or TRACER Capsids, and identify associated receptors to potentially enable high brain penetration with genetic medicines following intravenous, or IV, dosing. Its segment is developing and commercializing genetic medicine.

About SBFG SB Financial Group Inc.

SB Financial Group Inc that provides a range of community banking services, including commercial and consumer lending, personal and business banking, treasury management and merchant services, personal wealth management and brokerage services, and other financial services to individuals, businesses, and municipalities. It operates in a single segment, which is Banking.

Share on Social Networks: